The field of durable mechanical circulatory support (MCS) has undergone an incredible evolution over the past few decades, resulting in significant improvements in longevity and quality of life for advanced heart failure patients. Despite these successes, substantial opportunities for further improvements remain, including in pump design and ancillary technology, peri- and post-operative management, and the overall patient experience. Ideally, durable MCS devices would be fully implantable, automatically controlled, and minimize need for anticoagulation.

The field of durable mechanical circulatory support (MCS) has undergone an incredible evolution over the past few decades, resulting in significant improvements in longevity and quality of life for advanced heart failure patients. Despite these successes, substantial opportunities for further improvements remain, including in pump design and ancillary technology, peri- and post-operative management, and the overall patient experience. Ideally, durable MCS devices would be fully implantable, automatically controlled, and minimize need for anticoagulation.

The field of durable mechanical circulatory support (MCS) has undergone an incredible evolution over the past few decades, resulting in significant improvements in longevity and quality of life for advanced heart failure patients. Despite these successes, substantial opportunities for further improvements remain, including in pump design and ancillary technology, peri- and post-operative management, and the overall patient experience. Ideally, durable MCS devices would be fully implantable, automatically controlled, and minimize need for anticoagulation.